Article: Drugs of Tomorrow 2002: Colorectal Cancer Colorectal Cancer Market from 2002 to 2010; http://www.smi-online.co.uk/1740a.asp.

Article: Colorectal Cancer, NSCLC, Breast and Ovarian Cancer ...
M2 Presswire;  November 7, 2006 ;     700+ words ... ... and Markets: Colorectal Cancer, NSCLC, Breast ... Development - The Cancer Market Outlook To ... indications in the cancer market, identifying ... companies in the cancer market and ensure ... profiles.- Colorectal cancer, NSCLC, breast ...

Article: Establishing First-line Therapy Use is the Biggest Challenge ...
Business Wire;  May 25, 2005 ;     700+ words ... ... therapy in the U.S. colorectal cancer market is becoming increasingly ... Therapeutics in the U.S. Colorectal Cancer Market, reveals that revenue ... Therapeutics in the U.S. Colorectal Cancer Market - then send an email to ...

Article: Research and Markets: the Global Colorectal Cancer ...
Business Wire;  May 10, 2004 ;     700+ words ... ... 2002, which means that colorectal cancer is the third most common ... stage cases. The global colorectal cancer market has been estimated in 2001 ... currently dominates the US colorectal cancer market, but severe diarrhea as ...

Article: Small, Highly Concentrated Nature of the Colorectal ...
PR Newswire;  December 20, 2007 ;     700+ words ... ... Comes to Mind When Treating Colorectal Cancer, According to a New Report ... concentrated nature of the colorectal cancer market kept promotional spend among ... Brands & Strategies: Colorectal Cancer, the leading competitors ...

Article: Drugs of Tomorrow 2002: Colorectal Cancer.
M2 Presswire;  February 18, 2003 ;     700+ words ... ... increase in the value of the colorectal cancer market will take on a more exponential ... invaluable insight into the colorectal cancer market from 2002 to 2010, and ... cytotoxics market; * the colorectal cancer market will benefit from incremental ...

Article: New Report Available at MarketResearch.com Details Breakthrough ...
M2 Presswire;  August 4, 2004 ;     700+ words ... ... Avastin and Erbitux into the colorectal cancer market will raise the standard ... their presence in the colorectal cancer market. Signal transduction ... opportunities and risks in the colorectal cancer market by analyzing the clinical ...

Article: Use of Avastin and Erbitux in the Adjuvant Setting and Launches ...
PR Newswire;  March 11, 2009 ;     700+ words ... ... s Erbitux will drive the colorectal cancer market to grow by $900 million ... Pharmacor report entitled Colorectal Cancer finds that market growth ... oxaliplatin in the U.S. colorectal cancer market in late 2009 and in Japan ...